Inozyme (Series A)
Funding Details
- Awarder
- Inbox
- Date Award
- November 15, 2017
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $49,000,000
Company Info
- Founding Year
- 2016
- Founders
- Axel Bolte
- Company Description
- Inozyme is a biopharmaceutical company developing therapeutics for rare diseases, with a focus on bone health.
- Market
- Rare diseases
- Location
- Cambridge, MA, USA
- Coinvestors
- Longitude Capital, Novo Ventures, Sanofi Ventures